AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22884063
Drug: 100 mg/d
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/d oral progesterone
Trial: 22884063
Drug: 200 mg/d
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/d oral progesterone
Trial: 22884063
Drug: 300 mg/d
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/d oral progesterone
Trial: 22884063
Drug: 400 mg/d
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/d oral progesterone
Trial: 2672062
Drug: Bright light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright light therapy at high intensity (2000 lux)
Trial: 2672062
Drug: Bright light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bright light therapy at low intensity (300 lux)
Trial: 30859660
Drug: Turmeric (2,100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turmeric (2,100 mg powdered rhizome of turmeric daily)
Trial: 16582864
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid (2.2 g, single dose 30 min before surgery)
Trial: 16582864
Drug: Cefazolin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (2 g, single dose 30 min before surgery)
Trial: 12837854
Drug: CP-346086 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-346086 (10 mg/kg/day) for 2 weeks
Trial: 12837854
Drug: CP-346086 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-346086 (single oral dose of 100 mg)
Trial: 12837854
Drug: CP-346086 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-346086 (single oral dose of 1.3 mg/kg)
Trial: 12837854
Drug: CP-346086 (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-346086 (30 mg/day for 2 weeks)
Trial: 8621785
Drug: L-arginine (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (7 grams x 3/day)
Trial: 1413587
Drug: UHF therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UHF therapy
Trial: 3890140
Drug: Atropine (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (not specified dosage or duration)
Trial: 3890140
Drug: GIP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GIP infusion without atropine
Trial: 31915366
Drug: venetoclax +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: venetoclax + hypomethylating agent
Trial: 18315507
Drug: Alpha-lipoic acid
RxNorm normalized name: Alpha-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-lipoic acid (ALA) 300 mg three times a day for 6 months
Trial: 15966876
Drug: Active laser
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active laser treatment with wavelengths of 635 and 830 nm
Trial: 7758260
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (60 U at 0 min)
Trial: 7758260
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (120 U at 0 min)
Trial: 7758260
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (60 U at 0 and +20 min)
Trial: 7758260
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (120 U at +20 min)
Trial: 7758260
Drug: Post‐prandial intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post‐prandial intravenous insulin
Trial: 2083922
Drug: ICS 205-930
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS 205-930 (20 mg infused intravenously)
Trial: 227180
Drug: 1 gm.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 gm. l‐tryptophan
Trial: 227180
Drug: 3 gms.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 gms. l‐tryptophan
Trial: 19386792
Drug: Exogenous PTH
RxNorm normalized name: PTH
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Exogenous PTH administered subcutaneously to male Sprague-Dawley rats
Trial: 17244215
Drug: Timolol‐dorzolamide combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol‐dorzolamide combination twice daily
Trial: 15821205
Drug: IV ampicillin/sulbactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ampicillin/sulbactam (normal dose)
Trial: 15821205
Drug: IV ampicillin/sulbactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ampicillin/sulbactam (half dose)
Trial: 9219402
Drug: Cefixime 200
RxNorm normalized name: cefixime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 200 mg daily for 5 days
Trial: 9219402
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V 250 mg four times a day for 5 days
Trial: 7715474
Drug: 1.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/day percutaneous 17 beta‐oestradiol (E2) for 36 months
Trial: 7715474
Drug: 0.625 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg/day oral conjugated oestrogens (CEE) for 24 months
Trial: 23478748
Drug: ω-3 PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ω-3 PUFA supplementation (1.2 g per day)
Trial: 22614774
Drug: Laninamivir octanoate
RxNorm normalized name: Laninamivir octanoate
DrugBank: Laninamivir octanoate (DB11888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laninamivir octanoate (LO) 20 or 40 mg (depending on age), single inhalation
Trial: 22614774
Drug: Zanamivir (ZN)
RxNorm normalized name: Zanamivir
DrugBank: Zanamivir (DB00558)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanamivir (ZN) 20 mg, inhaled twice daily for 5 days
Trial: 19610037
Drug: Herbal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal therapy treatment (PT)
Trial: 19610037
Drug: Topical antibiotic
RxNorm normalized name: Tetracycline and derivatives, topical antibiotics
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical antibiotic treatment (C)
Trial: 15936869
Drug: Darifenacin immediate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin immediate release (IR) 2.5 mg t.i.d.
Trial: 15936869
Drug: Oxybutynin 2.5
RxNorm normalized name: oxyBUTYnin 2.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin 2.5 mg t.i.d.
Trial: 15936869
Drug: Darifenacin controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin controlled release (CR) 15 mg q.d.
Trial: 15936869
Drug: Darifenacin CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin CR 30 mg q.d.
Trial: 15936869
Drug: Darifenacin CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darifenacin CR (both doses)
Trial: 15936869
Drug: Oxybutynin (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin (both doses)
Trial: 15229420
Drug: Endoscopic epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endoscopic epinephrine injection (1:10,000 solution, mean volume 18.0 mL)
Trial: 10743448
Drug: Fentanyl 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.15 mg followed by fentanyl 0.05 mg
Trial: 10743448
Drug: Morphine 15
RxNorm normalized name: morphine 15 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 15 mg followed by morphine 7 mg
Trial: 2413307
Drug: Clonidine (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.15 mg i.v.)
Trial: 19151305
Drug: Ultrasound-guided anterior
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided anterior approach to sciatic nerve block with 1.5% mepivacaine 20 mL and epinephrine
Trial: 19151305
Drug: Ultrasound-guided posterior
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided posterior (subgluteal) approach to sciatic nerve block with 1.5% mepivacaine 20 mL and epinephrine
Trial: 16512755
Drug: Chlorhexidine varnish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorhexidine varnish administration
Trial: 3773023
Drug: Intravenous solution
RxNorm normalized name: Intravenous Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous solution (IV) only
Trial: 3773023
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration along with intravenous solution (ORS/IV)
Trial: 20728874
Drug: Sleep therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sleep therapy
Trial: 15717256
Drug: Once-daily emtricitabine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily emtricitabine, didanosine, and efavirenz (n=178)
Trial: 15717256
Drug: Protease inhibitor
RxNorm normalized name: Protease inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitor (PI) based regimen (n=177)
Trial: 15717256
Drug: Once-daily emtricitabine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily emtricitabine, didanosine, and efavirenz
Trial: 12860502
Drug: Linezolid (i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linezolid (i.v. 600 mg BID for 7-28 days or switched to oral 600 mg BID)
Trial: 12860502
Drug: Teicoplanin (i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin (i.v. alone or switched to i.m. administration)
Trial: 10493326
Drug: Integrated outpatient
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated outpatient treatment (IOT)
Trial: 10493326
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard alcoholism treatment)
Trial: 1836425
Drug: Goserelin (3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin (3.6 mg/4 weeks s.c., n = 20)
Trial: 1836425
Drug: Danazol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (2 x 400 mg/day p.o., n = 13)
Trial: 7042363
Drug: Indoprofen 300
RxNorm normalized name: Neoprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indoprofen 300 mg/day
Trial: 7042355
Drug: Indomethacin 75
RxNorm normalized name: indomethacin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 75 mg/day
Trial: 15367922
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g alcohol/day
Trial: 15367922
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g alcohol/day
Trial: 12218503
Drug: Patient-controlled analgesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled analgesia with bolus intravenous doses of 1 mg morphine for 3 days
Trial: 9800817
Drug: Polytetrafluoroethylene patches
RxNorm normalized name: polytetrafluoroethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polytetrafluoroethylene patches
Trial: 9800817
Drug: Polyglycolic acid
RxNorm normalized name: polyglycolic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyglycolic acid patches
Trial: 2777422
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of sustained-release urapidil (Ebrantil 60)
Trial: 2777422
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg urapidil (fast-release tablet)
Trial: 23934387
Drug: US-guided IA
RxNorm normalized name: magnesium aluminum silicate type Ia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: US-guided IA injection
Trial: 23934387
Drug: Palpation-guided IA
RxNorm normalized name: magnesium aluminum silicate type Ia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palpation-guided IA injection
Trial: 23934387
Drug: Both US-guided
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both US-guided and palpation-guided IA injections
Trial: 15673896
Drug: Spinal 2-chloroprocaine
RxNorm normalized name: 2-chloroprocaine
DrugBank: Chloroprocaine (DB01161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spinal 2-chloroprocaine (30 mg)
Trial: 15673896
Drug: Procaine (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaine (80 mg)
Trial: 14738262
Drug: Midazolam 0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.02 mg x kg(-1) followed by thiopentone 3 mg x kg(-1)
Trial: 9737654
Drug: Sodium-channel blockers
RxNorm normalized name: Channel catfish
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium-channel blockers
Trial: 9737654
Drug: Chronic antiarrhythmic
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic antiarrhythmic therapy
Trial: 9737654
Drug: Recognition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recognition of proarrhythmia and withdrawal of offending agents
Trial: 6804113
Drug: Long-acting propranolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting propranolol, 160 mg once daily for 4 weeks
Trial: 6804113
Drug: Standard propranolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard propranolol, 40 mg four times daily for 4 weeks
Trial: 31222951
Drug: Roxadustat 50
RxNorm normalized name: Roxadustat 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxadustat 50 or 70 mg three times weekly (ESA-Naïve group)
Trial: 31222951
Drug: Roxadustat 70
RxNorm normalized name: Roxadustat 70 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxadustat 70 or 100 mg three times weekly (ESA-Converted group)
Trial: 28744099
Drug: Verinurad (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad (40 mg, single dose)
Trial: 28744099
Drug: Verinurad (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad (10 mg, multiple dose)
Trial: 28744099
Drug: Verinurad (≥2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad (≥2 mg)
Trial: 28744099
Drug: Verinurad (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad (single and multiple doses)
Trial: 28744099
Drug: Verinurad (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verinurad (multiple daily doses)
Trial: 27046160
Drug: Ticagrelor (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (90 or 60 mg twice daily)
Trial: 19938709
Drug: Synthetic colloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic colloid solutions
Trial: 17674759
Drug: Group A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A: Postoperative management at one week after operation, then weekly for the first and second month, bi-weekly for the third and fourth month, and monthly after the fifth month.
Trial: 17674759
Drug: Group B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B: Postoperative management at two weeks after operation, then bi-weekly for the first and second month, monthly from third to fifth month, and bi-monthly after sixth month.
Trial: 15206017
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg procaine hydrochloride
Trial: 11199949
Drug: Alprazolam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (2 mg/day)
Trial: 9472839
Drug: Fluoxetine 60
RxNorm normalized name: fluoxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 60 mg/24 hr for 8 weeks
Trial: 20957498
Drug: lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lansoprazole 30 mg once daily
Trial: 7594335
Drug: famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 20 mg twice daily
Trial: 2174652
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml 0.75% prilocaine hydrochloride with 5 ml 8.4% sodium bicarbonate
Trial: 25209545
Drug: In-feed ZnO
RxNorm normalized name: Zinc Oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: In-feed ZnO at 3000 mg/kg
Trial: 25209545
Drug: Control feed
RxNorm normalized name: SYRINGE,FEEDING,THUMB CONTROL RING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control feed with 100 mg ZnO/kg
Trial: 25046055
Drug: Mitiglinide 10
RxNorm normalized name: mitiglinide
DrugBank: Mitiglinide (DB01252)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Mitiglinide 10 mg and voglibose 0.2 mg (three-times-daily before each meal)
Trial: 25046055
Drug: Mitiglinide 10
RxNorm normalized name: mitiglinide
DrugBank: Mitiglinide (DB01252)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Mitiglinide 10 mg and voglibose 0.2 mg (twice-daily before breakfast and dinner)
Trial: 22119455
Drug: Budesonide/formoterol maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol maintenance and reliever therapy (Symbicort SMART) at 2 × 2 (160/4.5 μg)
Trial: 22119455
Drug: Budesonide/formoterol maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol maintenance and reliever therapy (Symbicort SMART) at 1 × 2 (160/4.5 μg)
Trial: 14716472
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg, single oral dose)
Trial: 10024837
Drug: Intravenous quinaprilat
RxNorm normalized name: quinaprilat
DrugBank: Quinaprilat (DB14217)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous quinaprilat (2.5, 5, or 10 mg BID)
Trial: 10024837
Drug: Oral quinapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral quinapril (10, 20, or 40 mg OD)
Trial: 10024837
Drug: Oral quinapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral quinapril
Trial: 752875
Drug: Adjuvant BCG
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant BCG immunotherapy (intradermal and oral BCG)
Trial: 21774288
Drug: Fentanyl-propofol group
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fentanyl-propofol group (1 mcg/kg fentanyl)
Trial: 15175887
Drug: Dorsal block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorsal block splinting of the PIP joint with daily active exercise (Group B)
Trial: 11775046
Drug: Selective Serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective Serotonin Reuptake Inhibitors (SSRIs, N = 748)
Trial: 9863097
Drug: Theo-polyphenols (TP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theo-polyphenols (TP) treatment
Trial: 7934599
Drug: Topical bovine
RxNorm normalized name: thrombin topical bovine 5000 intl units topical kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical bovine collagen applied weekly to the wound
Trial: 3391871
Drug: Erythromycin stearate
RxNorm normalized name: Erythromycin Stearate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate (ES) 500 mg tid
Trial: 27921320
Drug: Amiselimod 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiselimod 0.8 mg
Trial: 25195813
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAT, aspirin and clopidogrel)
Trial: 23449607
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg for 26 weeks
Trial: 21814477
Drug: Control (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Group A): Intralipid(®) 2 ml as a placebo 15 min before the cervical plexus block and at the end of the surgery
Trial: 21814477
Drug: Routine analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine analgesia (Group B): Placebo 15 min before the cervical plexus block and flurbiprofen 50 mg at the end of the surgery
Trial: 21814477
Drug: Preemptive analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive analgesia (Group C): Intravenous flurbiprofen 50 mg 15 min before the cervical plexus block and a placebo at the end of the surgery
Trial: 17043939
Drug: 10 mmHg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mmHg CO(2) pneumoperitoneum + intraperitoneal normal saline infusion (Group C)
Trial: 15853118
Drug: DHA enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA enriched foods (2 g fish oils)
Trial: 15853118
Drug: Soya-protein (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soya-protein (25 g)
Trial: 26883689
Drug: 600 IU
RxNorm normalized name: Vitamin E 4600 IU/5 ML Oral Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 IU vagitocin (oxytocin containing gel)
Trial: 24998009
Drug: Pump treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pump treatment
Trial: 22904246
Drug: OMT (Osteopathic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OMT (Osteopathic Manipulative Treatment)
Trial: 12601105
Drug: IFNbeta treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta treatment (Avonex, Betaferon, Rebif-22)